Combination oral antifungal therapy for paediatric fungal infection: An option to improve efficacy and overcome clinical resistance
Australasian Journal of Dermatology · 2024
DOI: 10.1111/ajd.14186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australasian Journal of Dermatology, 2024. Verfasst von Nisal Punchihewa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Eastern Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Antifungal Agents, Dermatomycoses. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
There is increasing evidence of clinically resistant cutaneous fungal infections. The use of combination oral antifungals is described in adults but not in paediatric patients. We present seven paediatric cases of clinically resistant fungal infections treated successfully with combination oral antifungal therapy after inadequate response to a single agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Eastern Health, Melbourne, Victoria, Australia.
- Royal Children's Hospital, Melbourne, Victoria, Australia.
ORCID-Profile: Nisal Punchihewa, David Orchard
Zitieren
APA
Punchihewa, N., & Orchard, D. (2024). Combination oral antifungal therapy for paediatric fungal infection: An option to improve efficacy and overcome clinical resistance. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.14186
Vancouver
Punchihewa N, Orchard D. Combination oral antifungal therapy for paediatric fungal infection: An option to improve efficacy and overcome clinical resistance. Australasian Journal of Dermatology. 2024. doi:10.1111/ajd.14186
BibTeX
@article{Punchihewa2024,
author = {Punchihewa, Nisal and Orchard, David},
title = {Combination oral antifungal therapy for paediatric fungal infection: An option to improve efficacy and overcome clinical resistance},
journal = {Australasian Journal of Dermatology},
year = {2024},
doi = {10.1111/ajd.14186}
}
EUVIMED